PASITHEA THERAPEUTICS CORP. Other Nonoperating Income (Expense)
PASITHEA THERAPEUTICS CORP. (KTTA) reported Other Nonoperating Income (Expense) of $7.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-30.
Financial Statements › Income Statement › Other Income
us-gaap:OtherNonoperatingIncomeExpense · last filed 2026-08-14
- PASITHEA THERAPEUTICS CORP. other nonoperating income (expense) for the quarter ending 2025-12-31 was $0.00.
- PASITHEA THERAPEUTICS CORP. other nonoperating income (expense) for the quarter ending 2025-09-30 was $7.00K.
- PASITHEA THERAPEUTICS CORP. other nonoperating income (expense) for the quarter ending 2025-06-30 was $7.00K, a 93.88% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. other nonoperating income (expense) for the quarter ending 2025-03-31 was $7.00K, a 95.43% decline year-over-year.
- PASITHEA THERAPEUTICS CORP. other nonoperating income (expense) for fiscal 2025 was $7.00K.
- PASITHEA THERAPEUTICS CORP. other nonoperating income (expense) for fiscal 2023 was $471.61K, a 45.23% decline from fiscal 2022.
- PASITHEA THERAPEUTICS CORP. other nonoperating income (expense) for fiscal 2022 was $861.09K.
| Period end | Other Nonoperating Income (Expense) 3 month | Other Nonoperating Income (Expense) 3 month as first filed | Other Nonoperating Income (Expense) 6 month | Other Nonoperating Income (Expense) 9 month | Other Nonoperating Income (Expense) 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $7.00K derived: sum of 2 quarters · filed 2026-03-30 | $14.00K derived: sum of 3 quarters · filed 2026-08-14 | $7.00K 10-K · filed 2026-03-30 | |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-13 | $14.00K derived: sum of 2 quarters · filed 2026-08-14 | $7.00K 10-Q · filed 2025-11-13 | ||
| 2025-06-30 | $7.00K 10-Q · filed 2026-08-14 | $7.00K 10-Q · filed 2026-08-14 | |||
| 2025-03-31 | $7.00K 10-Q · filed 2026-05-15 | $7.17K 10-Q · filed 2025-05-15 | |||
| 2024-06-30 | $114.41K 10-Q · filed 2024-08-13 | $267.63K 10-Q · filed 2024-08-13 | |||
| 2024-03-31 | $153.22K 10-Q · filed 2024-05-14 | ||||
| 2023-12-31 | $471.61K 10-K · filed 2024-03-29 | ||||
| 2023-06-30 | $117.19K 10-Q · filed 2024-08-13 | $110.80K 10-Q · filed 2024-08-13 | |||
| 2023-03-31 | -$6.39K 10-Q · filed 2024-05-14 | ||||
| 2022-12-31 | $861.09K 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Rocket One Inc. (RKTO) | United States | $0.019B |